Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Michael Seckl"'
Autor:
Luz Angela Correa Ramírez, Izildinha Maestá, María Inés Bianconi, Gustavo Jankilevich, Silvina Otero, Carlos Raúl Villegas Mejía, Rafael Cortés-Charry, Kevin M. Elias, Neil S. Horowitz, Michael Seckl, Ross S. Berkowitz
Publikováno v:
Revista Brasileira de Ginecologia e Obstetrícia, Vol 44, Iss 8, Pp 746-754 (2022)
Abstract Objective There are few multinational studies on gestational trophoblastic neoplasia (GTN) treatment outcomes in South America. The purpose of this study was to assess the clinical presentation, treatment outcomes, and factors associated wit
Externí odkaz:
https://doaj.org/article/c7530bca781549b9b2a0ff3fda00e942
Autor:
Louisa Black, Alexandra Bowes, Michael Seckl, Geoffrey Maher, Baljeet Kaur, Joseph Arumainayagam, Sashi Acharya
Publikováno v:
Clinical Case Reports, Vol 11, Iss 3, Pp n/a-n/a (2023)
Abstract Epithelioid trophoblastic tumor (ETT) is a rare malignancy arising from neoplastic proliferation of chorionic‐type intermediate trophoblasts. ETT poses significant challenges to clinicians in the diagnosis and treatment and can hence lead
Externí odkaz:
https://doaj.org/article/4e2dbdb29d3e4cc3bf772d1969ecf04d
Insights into the hyperglycosylation of human chorionic gonadotropin revealed by glycomics analysis.
Autor:
Linda Ibeto, Aristotelis Antonopoulos, Paola Grassi, Poh-Choo Pang, Maria Panico, Shabnam Bobdiwala, Maya Al-Memar, Paul Davis, Mark Davis, Julian Norman Taylor, Paula Almeida, Mark R Johnson, Richard Harvey, Tom Bourne, Michael Seckl, Gary Clark, Stuart M Haslam, Anne Dell
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0228507 (2020)
Human chorionic gonadotropin (hCG) is a glycoprotein hormone that is essential for the maintenance of pregnancy. Glycosylation of hCG is known to be essential for its biological activity. "Hyperglycosylated" variants secreted during early pregnancy h
Externí odkaz:
https://doaj.org/article/6008519cd2254cfc92b99c5336db5b46
Publikováno v:
International Journal of Gynecologic Cancer. 33:414-419
The discovery that anti-programmed death-1 antibody (anti-PD-1) immunotherapy can cure patients with multidrug-resistant gestational trophoblastic neoplasia provides a new powerful and low toxicity treatment. This heralds an era within which the majo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d62263c59354546018ef5fac86b3123d
https://doi.org/10.1136/ijgc-2022-003771
https://doi.org/10.1136/ijgc-2022-003771
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b32858efe8830dab979264dda652192a
https://doi.org/10.1530/endoabs.91.wd9
https://doi.org/10.1530/endoabs.91.wd9
Autor:
Louisa Black, Alexandra Bowes, Michael Seckl, Geoffrey Maher, Baljeet Kaur, Joseph Arumainayagam, Sashi Acharya
Publikováno v:
Clinical Case Reports. 11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c2951fe4444689449338a3390095d1b
https://doi.org/10.1002/ccr3.7114
https://doi.org/10.1002/ccr3.7114
Autor:
Lara Ulrich (first author), Anand Sharma, Sarah Howlett, Alice Maxwell, Dee Short, Ignacio Vazquez, Roshan Agarwal, David Hrouda, Ethna Mannion, Edmund Wilkes, Jingky Lozano-Kuehne, Gordon Rustin, Terry Tin, Naveed Sarwar, Michael Seckl, Ehsan Ghorani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82ae025e7a0cc73b3e1c7a945be5413d
https://doi.org/10.2139/ssrn.4463523
https://doi.org/10.2139/ssrn.4463523
Autor:
Luz Angela Correa Ramírez, Izildinha Maestá, María Inés Bianconi, Gustavo Jankilevich, Silvina Otero, Carlos Raúl Villegas Mejía, Rafael Cortés-Charry, Kevin M. Elias, Neil S. Horowitz, Michael Seckl, Ross S. Berkowitz
Publikováno v:
Revista Brasileira de Ginecologia e Obstetrícia v.44 n.8 2022
Revista brasileira de ginecologia e obstetrícia
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia (FEBRASGO)
instacron:FEBRASGO
Revista Brasileira de Ginecologia e Obstetrícia, Volume: 44, Issue: 8, Pages: 746-754, Published: 07 OCT 2022
Revista brasileira de ginecologia e obstetrícia
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia (FEBRASGO)
instacron:FEBRASGO
Revista Brasileira de Ginecologia e Obstetrícia, Volume: 44, Issue: 8, Pages: 746-754, Published: 07 OCT 2022
Objective There are few multinational studies on gestational trophoblastic neoplasia (GTN) treatment outcomes in South America. The purpose of this study was to assess the clinical presentation, treatment outcomes, and factors associated with chemore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb0d71bdbe25ce15abdee82e29bf44d3
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032022000800746
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032022000800746
Autor:
Johnathan K, Joffe, Fay H, Cafferty, Laura, Murphy, Gordon J S, Rustin, Syed A, Sohaib, Rhian, Gabe, Sally P, Stenning, Elizabeth, James, Dipa, Noor, Simona, Wade, Francesca, Schiavone, Sarah, Swift, Elaine, Dunwoodie, Marcia, Hall, Anand, Sharma, Jeremy, Braybrooke, Jonathan, Shamash, John, Logue, Henry H, Taylor, Ivo, Hennig, Jeff, White, Sarah, Rudman, Jane, Worlding, David, Bloomfield, Guy, Faust, Hilary, Glen, Rachel, Jones, Michael, Seckl, Graham, MacDonald, Thiagarajan, Sreenivasan, Satish, Kumar, Andrew, Protheroe, Ramachandran, Venkitaraman, Danish, Mazhar, Victoria, Coyle, Martin, Highley, Tom, Geldart, Robert, Laing, Richard S, Kaplan, Robert A, Huddart
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(22)
PURPOSE Survival in stage I seminoma is almost 100%. Computed tomography (CT) surveillance is an international standard of care, avoiding adjuvant therapy. In this young population, minimizing irradiation is vital. The Trial of Imaging and Surveillan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32509283fdd8f055e025757fc245aebc
https://pubmed.ncbi.nlm.nih.gov/35298280
https://pubmed.ncbi.nlm.nih.gov/35298280
Autor:
Sophie Merrick, Matthew Nankivell, Matteo Quartagno, Caroline S. Clarke, Nalinie Joharatnam-Hogan, Tom Waddell, Brent O'Carrigan, Michael Seckl, Ehsan Ghorani, Emma Banks, Kim Edmonds, George Bray, Rose Woodward, Rachel Bennett, Jonathan Badrock, Will Hudson, Ruth E. Langley, Naveen Vasudev, Lisa Pickering, Duncan C. Gilbert
Publikováno v:
Contemporary Clinical Trials. 124:107030
Immune checkpoint inhibitors (ICI) have revolutionised treating advanced cancers. ICI are administered intravenously every 2-6 weeks for up to 2 years, until cancer progression/unacceptable toxicity. Physiological efficacy is observed at lower doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee2eb31d562e3cfbfcb4267098649cdf
https://doi.org/10.1016/j.cct.2022.107030
https://doi.org/10.1016/j.cct.2022.107030